Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development (PSIUSAD)
Prospective Study for Intestinal Ultrasound Algorithm Development
This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier to assess bowel inflammation.
The study will include adults who are healthy or who are having an intestinal ultrasound as part of care for inflammatory bowel disease, such as Crohn disease or ulcerative colitis. Researchers want to find out whether a computer program can measure bowel wall thickness from ultrasound images as accurately as experienced ultrasound clinicians. They will also explore whether the program can identify other changes in the bowel.
Participants will have an intestinal ultrasound as part of their usual care. People who agree to take part will allow the research team to use de-identified ultrasound images and a small amount of related health information. No medication, experimental treatment, or additional ultrasound procedure will be given for this study. The computer program will not be used to make decisions about a participant's care, and participants will not receive individual results from the program.
研究概览
详细说明
Inflammatory bowel disease, including Crohn disease and ulcerative colitis, requires reliable assessment of intestinal inflammation to support clinical monitoring and treatment decisions. Intestinal ultrasound is a non-invasive, point-of-care imaging method that can assess bowel inflammation without radiation exposure. However, its interpretation may vary by operator experience and local scanning practice.
This prospective, multicentre, observational study will collect de-identified intestinal ultrasound images, cine loops, and limited associated metadata from adults aged 18 years and older. Eligible participants may be healthy individuals with no known inflammatory bowel disease or individuals undergoing intestinal ultrasound for inflammatory bowel disease screening, monitoring, or another clinical reason. Intestinal ultrasound examinations will be performed as part of routine clinical care. The study does not add a treatment intervention, investigational drug, experimental device, or clinically directed diagnostic procedure.
Following informed consent, ultrasound images and cine loops generated during the routine examination will be exported in de-identified DICOM format. Limited information relevant to artificial intelligence development and validation, such as age, sex, self-reported race, pregnancy status, eligibility confirmation, and relevant scan-related or pre-existing clinical information, may also be recorded. Direct personal identifiers and personal health information will be removed before the data are transferred outside the clinical site.
The de-identified data will be reviewed for appropriate de-identification and formatting before secure transfer to Dova Health Intelligence Inc. The data will be annotated and used to develop, train, tune, and test computer vision algorithms designed to identify bowel structures and measure bowel wall thickness on intestinal ultrasound. The study will also assess the feasibility of developing algorithms to evaluate bowel wall layer stratification, luminal diameter, bowel wall flow, bowel wall scarring, gastrointestinal motility, and mesenteric fat proliferation.
The primary objective is to evaluate whether the computer vision algorithm prototype can measure bowel wall thickness with performance comparable to manual measurements by experienced sonographers. Secondary objectives include evaluating the quality, diversity, and usability of the collected ultrasound data for artificial intelligence development and assessing the feasibility of measuring additional intestinal ultrasound features.
The algorithms developed in this study are investigational and will not be used in routine clinical care during the study. No participant-level algorithm findings will be returned to participants, and participation is not expected to provide a direct clinical benefit. The primary foreseeable risk is a loss of confidentiality; this risk is mitigated through de-identification at the study site, verification of de-identification before transfer, secure file transfer, controlled access, and secure cloud-based storage. The study plans to enroll up to 95 participants internationally, including up to 30 participants at the British Columbia site.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Cristian A Massaro, MSc
- 电话号码:587-223-5248
- 邮箱:iusresearch@ibdcentrebc.ca
学习地点
-
-
British Columbia
-
Vancouver、British Columbia、加拿大、V6Z 2L2
- IBD Centre of BC
-
接触:
- Cristian A Massaro, MSc
- 电话号码:587-223-5248
- 邮箱:iusresearch@ibdcentrebc.ca
-
首席研究员:
- Matthew J Smyth, MD
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Adults aged 18 years or older.
- Individuals who are either healthy with no known finding of inflammatory bowel disease before the ultrasound examination or undergoing intestinal ultrasound for inflammatory bowel disease screening, monitoring, or another clinical reason.
- Individuals who are able and willing to provide informed consent for the collection and use of de-identified study data.
Exclusion Criteria:
- Individuals who do not meet the study demographic requirements.
- Individuals unable or unwilling to provide informed consent.
- Pregnant individuals.
- Individuals with health conditions managed using drugs or medical-device intervention, or with unmanaged conditions or conditions requiring monitoring, that could affect study eligibility or the ultrasound assessment.
- Individuals who have recently taken contrast-enhancing compounds.
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Intestinal Ultrasound Participants
This cohort includes adults aged 18 years and older who are either healthy or undergoing intestinal ultrasound for inflammatory bowel disease screening, monitoring, or another clinical reason.
Participants will undergo intestinal ultrasound as part of routine clinical care.
With informed consent, de-identified ultrasound images and cine loops, along with limited associated information such as age, sex, self-reported race, and relevant scan-related details, will be collected for artificial intelligence algorithm development.
No study drug, experimental treatment, or experimental device will be administered.
The artificial intelligence algorithms will not be used to guide participant care or provide individual diagnostic results during the study.
|
Intestinal ultrasound images and cine loops will be collected from adults undergoing ultrasound as part of routine clinical care.
Following informed consent, the images and cine loops will be de-identified and used for artificial intelligence algorithm development, training, tuning, and testing.
The study does not assign participants to receive an intervention, and the ultrasound is not performed solely for research purposes.
The artificial intelligence algorithms developed using the data will not be used to guide participant care or provide individual diagnostic results during the study.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Artificial Intelligence-Generated Bowel Wall Thickness Measurement Agreement
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Agreement between bowel wall thickness measurements generated by the artificial intelligence computer-vision algorithm and manual bowel wall thickness measurements performed by experienced sonographers using de-identified intestinal ultrasound images and cine loops.
Agreement will be assessed using the pre-specified performance metric in the statistical analysis plan.
|
Day 1, after completion of the intestinal ultrasound examination
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Bowel Wall Layer Stratification Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall layer stratification.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Luminal Diameter Measurement Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable luminal diameter measurement.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Bowel Wall Flow Assessment Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall flow assessment.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Bowel Wall Scarring Assessment Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall scarring assessment.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Gastrointestinal Motility Assessment Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable gastrointestinal motility assessment.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Mesenteric Fat Proliferation Assessment Feasibility
大体时间:Day 1, after completion of the intestinal ultrasound examination
|
Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable assessment of mesenteric fat proliferation.
|
Day 1, after completion of the intestinal ultrasound examination
|
|
Proportion of Cine Loops Suitable for AI Development
大体时间:At completion of dataset preparation
|
Percentage of collected de-identified cine loops that meet all pre-specified completeness, image-quality, and required-metadata criteria for artificial intelligence algorithm training, tuning, and testing.
|
At completion of dataset preparation
|
合作者和调查者
调查人员
- 首席研究员:Matthew J Smyth, MD、University of British Columbia, IBD Centre of BC
出版物和有用的链接
一般刊物
- Novak KL, Nylund K, Maaser C, Petersen F, Kucharzik T, Lu C, Allocca M, Maconi G, de Voogd F, Christensen B, Vaughan R, Palmela C, Carter D, Wilkens R. Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease. J Crohns Colitis. 2021 Apr 6;15(4):609-616. doi: 10.1093/ecco-jcc/jjaa216.
- Goodsall TM, Nguyen TM, Parker CE, Ma C, Andrews JM, Jairath V, Bryant RV. Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease. J Crohns Colitis. 2021 Jan 13;15(1):125-142. doi: 10.1093/ecco-jcc/jjaa129.
- Jauregui-Amezaga A, Rimola J. Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease. Life (Basel). 2021 Jun 23;11(7):603. doi: 10.3390/life11070603.
- Frias-Gomes C, Torres J, Palmela C. Intestinal Ultrasound in Inflammatory Bowel Disease: A Valuable and Increasingly Important Tool. GE Port J Gastroenterol. 2021 Nov 23;29(4):223-239. doi: 10.1159/000520212. eCollection 2022 Jul.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- H26-00188
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.